688176 亞虹醫藥
按盤價 
5.810 +0.340 (+6.216%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -8.051 | -15.524 | -8.525 | -12.303 | -59.210 |
| 總資產報酬率 ROA (%) | -7.249 | -14.545 | -8.256 | -11.919 | -53.964 |
| 投入資產回報率 ROIC (%) | -7.550 | -15.076 | -8.472 | -12.247 | -30.787 | 邊際利潤分析 |
| 銷售毛利率 (%) | 78.552 | 78.998 | 73.022 | 84.989 | -- |
| 營業利潤率 (%) | -229.125 | -2,937.490 | -948,649.406 | -5,210,058.993 | -- |
| 息稅前利潤/營業總收入 (%) | -247.781 | -3,197.334 | -1,037,721.275 | -5,122,199.049 | -- |
| 淨利潤/營業總收入 (%) | -228.995 | -2,914.455 | -944,804.606 | -5,135,637.810 | -- | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 105.536 | 107.943 | 125.221 | 108.671 | 102.072 |
| 價值變動淨收益/利潤總額(%) | -7.094 | -6.324 | -23.476 | -6.975 | -1.484 |
| 營業外收支淨額/利潤總額(%) | 0.147 | -0.623 | -0.932 | -1.533 | 0.111 | 償債能力分析 |
| 流動比率 (X) | 10.129 | 12.816 | 34.217 | 40.716 | 21.973 |
| 速動比率 (X) | 10.119 | 12.808 | 34.182 | 40.665 | 21.860 |
| 資產負債率 (%) | 10.633 | 9.213 | 3.583 | 2.774 | 4.407 |
| 帶息債務/全部投入資本 (%) | 4.909 | 3.065 | -0.130 | 0.176 | -- |
| 股東權益/帶息債務 (%) | 1,890.660 | 3,089.060 | -76,383.985 | 56,417.493 | 3,393,755.384 |
| 股東權益/負債合計 (%) | 839.911 | 984.723 | 2,690.805 | 3,504.356 | 2,169.060 |
| 利息保障倍數 (X) | 13.526 | 11.500 | 10.607 | -558.185 | -146.557 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 45.192 | 113.751 | 141.021 | 342.000 | -- |
| 存貨周轉天數 (天) | 18.265 | 274.394 | 168,675.349 | 2,100,090.830 | -- |
| 備註： | 即時報價更新時間為 27/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
